Evolva’s shareholders give green light for Lallemand to acquire financially challenged firm

22 Dec 2023 — Evolva Holding SA, a leader in natural molecules and industrial biotech, held an extraordinary general meeting (EGM) on December 21, 2023, where its shareholders approved a series of critical proposals presented by the Board of Directors, including the sale of Evolva AG to Danstar Ferment AG, a Swiss affiliate of Lallemand.